{"id":1636282,"name":"Aeglea BioTherapeutics Inc","transferAgent":{"dtcMemberId":7805,"name":" AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC/DRS                      "},"allClaimedTransferAgents":[{"dtcMemberId":7805,"name":" AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC/DRS                      ","asOfDate":{"value":"2022-04-21"},"docUrl":"https://www.sec.gov/Archives/edgar/data/1636282/000156459022015010/agle-def14a_20220421.htm"},{"dtcMemberId":7805,"name":"American Stock Transfer & Trust Company","asOfDate":{"value":"2020-12-17"},"docUrl":"https://www.nasdaqtrader.com/content/home/help/samplereports/Fundamental_Data_cusip121720.xlsx"}],"tickers":[{"ticker":"AGLE","exchange":"Nasdaq","description":"Common Stock","hasOnlinePurchase":null,"cusip":"00773J103"}],"holders":{"filingDate":{"value":"2022-03-08"},"totalHolders":20,"docUrls":["1636282/000156459022008995/agle-10k_20211231.htm"]}}